Altimmune, Inc.
Altimmune, Inc. (ALT) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
alt · stock forecast · 15 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 15 Wall Street analysts in the past 3 months
Buy
15 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$20.00
Consensus
$11.25
+310.7% upside
Low
$2.50
Median: $11.25 · Last Close: $2.74
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$11.25
310.7% upside
High Target
$20
630.2%
Low Target
$2.5
-8.7%
Current Price
$2.74
as of today
Based on analyst price targets, the ALT stock price prediction for the next 12 months ranges from $2.5 to $20. The consensus ALT price forecast of $11.25 implies 310.7% upside from the current price of $2.74.
Short-Term Price Prediction
BearAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $2.67 | ↓ 2.61% |
1-day model range: $2.64–$2.69. Peak: $2.69 (-2.61%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ALT · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-14 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2026-03-16 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-06 | B. Riley Securities | Maintains | Buy→Buy |
| 2025-11-07 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2025-10-20 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-10-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-13 | UBS | Maintains | Buy→Buy |
| 2025-08-13 | B. Riley Securities | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Altimmune, Inc. (ALT) stock. Of the recent 64 rating actions, 0 were upgrades and 3 were downgrades. 15 analysts currently cover ALT.
Analyst Recommendation Trends
ALT analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 2 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$0M
↓ 100.0% YoY
Revenue Next Year
$26M
↑ 501964.4% YoY
EPS This Year
$-0.69
EPS Next Year
$-0.76
↑ 11.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast ALT EPS of $-0.69 for the current fiscal year, based on estimates from 6 analysts. The ALT revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The ALT stock forecast is supported by two independent data sources: analyst consensus ratings from 15 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ALT price target is $11.25 (+310.7% upside), with an analyst consensus of Buy.
The ALT short-term stock prediction for tomorrow is $2.67 (-2.61%).
Altimmune, Inc. trades on NASDAQ under the ticker ALT. The ALT stock outlook for 2027 is broadly positive, supported by a Buy consensus among 80% of covering analysts.
Frequently asked questions
ALT forecast · 8 questionsAccording to 15 Wall Street analysts, the average 12-month ALT price target is $11.25, with a high forecast of $20.00 and a low of $2.50. The median price target is shown in the chart above when available. This implies +310.7% potential upside from the current price of $2.74.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.